Replies to post #3210 on Arrayit Corporation (ARYC)

[Bartlman]

I agree with your assessment of OvaDx and its prognosis dr. It's a mess and best forgotten short term and maybe long as well. I also agree that with the proliferation of genomic testing and all the things that ArrayIt and other companies enable, there will be many competitors appearing. To the quick goes the race, so they say and ARYC has been anything but quick on this one. I do believe, however, that this other avenue being pursued by the company, genetic testing, has the potential to be far more profitable and, so far, is not involved in any legal messiness.